MarketInOut Stock Screener Log In | Sign Up

EssilorLuxottica S.A.

PAR • Healthcare • Medical Instruments & Supplies • Quote as of 10/27/2026 17:35
EssilorLuxottica S.A. stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangePAR
Market Capitalization81,384 mln
Float306 mln
Earnings Date02/11/2027

EPS

5.35
Stretched

P / E

33.95
Overvalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.65
Likely reliable

1-Year Forecast

215.91
Attractive

Relative Strength

99 / 100
Top performer

Business Description

EssilorLuxottica is a Paris-based company founded in 1849 that makes and sells a wide range of vision products, including prescription lenses, eyeglass frames, sunglasses, and contact lenses, through well-known brands such as Ray-Ban, Oakley, Transitions, and Varilux. The company also develops professional eye care tools and imaging systems used by opticians, eye doctors, and medical institutions around the world. Its products reach customers through independent opticians, large retail chains, and online channels across every major region of the world.

Key Fundamentals

EPS5.35
P/E33.95
ROE6.45
RPS63.46
ROIC4.51
ROA3.92
Interest Cover10.20
EBITDA, mln6,948
EV / EBITDA11.81
EV / EBIT21.48
Revenue, mln29,285
EV / Revenue2.80

Quote Details

Last 181.80
Change 6.8 (3.89%)
Open 174.05
Volume 1,207,873
Turnover 219,591,312
Average Volume 906,766

Financial Ratios

Pre-Tax Profit Margin12
Leverage Ratio1.66
Current Ratio0.89
Price / Book1.67
Price / Cash Flow15.49
Price / Free Cash Flow16.44
Debt / Equity0.39
Price / Sales2.32
PEG Ratio1.66

Financial Strength

Altman Z-Score2.63
Piotroski F-Score 6 / 9
Beneish M-Score-2.65
Price to Intrinsic Value0.87
Price to Lynch Fair Value1.74
1-Year Target Price215.91
Shiller PE Ratio34.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 20.8% 99 / 100   
1 Month 24.44% 99 / 100   
2 Months 12.29% 92 / 100   
6 Months 7.38% 69 / 100   
1 Year -41.77% 11 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog